Open Calls
-
Research, Innovation and Technology Call for Proposals (RITC) 2026
EP PerMed has launched its first research, innovation and technology call (RITC2026) for proposals on “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine”, acronym “MultiPMData2026”. In total, 19 funding organisations participate in this call with an available budget of over 14.8 Mio. € (approx.).
Upcoming Calls
-
Twinning Call 2026
Advancing Collaborative Implementation of Personalised Medicine Approaches in Healthcare
Closed Calls
-
Fast Track Validation Programme – Call Announcement
The Call is closed! The EP PerMed Fast Track Call closed in June 2025. Call statistics are available here. Introduction Personalised Medicine (PM) represents a paradigm shift from a “one size fits all” approach to an optimised strategy for the prevention, diagnosis and treatment of disease for each individual, based on their unique characteristics, including…
-
EP PerMed Joint Transnational Call (JTC) 2025
EP PerMed has launched its second joint transnational call (JTC2025) for proposals on “Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)”. In total, 35 funding organisations participate in this call with an available budget of over 36.5 Mio. € (approx.).
-
Education Call: Guide to Personalised Medicine for Healthcare Professionals
The purpose of this call is to support the provision and development of educational content for healthcare professionals on the implementation of personalised medicine. Submission The objective of this Call is to provide subgrant funding to support the provision and development of educational content aimed at healthcare professionals (HCPs) in the implementation of personalised medicine…
-
Venture Creator
Introduction Personalised Medicine (PM) represents a paradigm shift from a “one size fits all” approach to an optimised strategy for the prevention, diagnosis and treatment of disease for each individual, based on their unique characteristics, including biological features (e.g., phenotype, endotype, genotype), as well as lifestyle and environmental factors. Accordingly, PM puts the patient at…
-
Fast Track Call
Eight outstanding projects were selected for the EP PerMed Fast Track Validation Programme, an initiative designed to accelerate the development, validation, and adoption of innovative personalised medicine (PM) solutions across Europe. Call Announcement The call documents of the EP PerMed Fast Track Validation Programme were published on 10 December 2024. The call is closed, but…
-
Networking Support Call (NSC) 2025
Networking opportunity for previously funded projects in personalised medicine Rationale for organising Networking Support Calls EP PerMed’s rationale for organising Networking Support Calls (NSC) is to encourage networking in the field of personalised medicine (PM) and thereby stimulating the translation and implementation of research outcomes into clinical practice. The vision of EP PerMed, as described…
-
EP PerMed Joint Transnational Call for Proposals (2024)
The European Partnership for Personalised Medicine (EP PerMed) Joint Transnational Call for Proposals 2024 (JTC2024) marks a significant step in aligning strategies and advancing collaborative research efforts in the field of personalised medicine (PM) between different countries and European national regions. Aiming to foster innovation and reinforce the competitiveness of European research, the call brought…
